Concurrent Investment Advisors, LLC Humacyte, Inc. Transaction History
Concurrent Investment Advisors, LLC
- $3.39 Trillion
- Q3 2024
A detailed history of Concurrent Investment Advisors, LLC transactions in Humacyte, Inc. stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 13,800 shares of HUMA stock, worth $73,416. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,800Holding current value
$73,416% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HUMA
# of Institutions
136Shares Held
31.1MCall Options Held
323KPut Options Held
582K-
Black Rock Inc. New York, NY7.14MShares$38 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$25.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$15.3 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.86MShares$9.9 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.6MShares$8.51 Million0.0% of portfolio
About Humacyte, Inc.
- Ticker HUMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 103,007,000
- Market Cap $548M
- Description
- Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...